{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:48:45Z","timestamp":1791254925811,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07454-7","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:30:20Z","timestamp":1764606620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["EMP1\u2009+\u2009hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma and predict prognosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jie","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9812-5415","authenticated-orcid":false,"given":"Tongyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"3","key":"7454_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18(3):151\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00372-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7454_CR2","doi-asserted-by":"publisher","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4). https:\/\/doi.org\/10.3390\/cells9040875.","DOI":"10.3390\/cells9040875"},{"issue":"39","key":"7454_CR3","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.3748\/wjg.v26.i39.5919","volume":"26","author":"A Campos-Murgu\u00eda","year":"2020","unstructured":"Campos-Murgu\u00eda A, Ruiz-Marg\u00e1in A, Gonz\u00e1lez-Regueiro JA, Mac\u00edas-Rodr\u00edguez RU. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol. 2020;26(39):5919\u201343. https:\/\/doi.org\/10.3748\/wjg.v26.i39.5919.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"7454_CR4","doi-asserted-by":"publisher","first-page":"030501","DOI":"10.11613\/BM.2022.030501","volume":"32","author":"G Aleknavi\u010di\u016bt\u0117-Valien\u0117","year":"2022","unstructured":"Aleknavi\u010di\u016bt\u0117-Valien\u0117 G, Banys V. Clinical importance of laboratory biomarkers in liver fibrosis. Biochem Med (Zagreb). 2022;32(3):030501. https:\/\/doi.org\/10.11613\/BM.2022.030501.","journal-title":"Biochem Med (Zagreb)"},{"issue":"10308","key":"7454_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X.","journal-title":"Lancet"},{"issue":"1","key":"7454_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014.","journal-title":"J Hepatol"},{"issue":"18","key":"7454_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2023.5997","volume":"329","author":"EB Tapper","year":"2023","unstructured":"Tapper EB, Parikh ND. Diagnosis and management of cirrhosis and its complications: A review. JAMA. 2023;329(18):1589\u2013602. https:\/\/doi.org\/10.1001\/jama.2023.5997.","journal-title":"JAMA"},{"key":"7454_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1\u201361. https:\/\/doi.org\/10.1016\/bs.acr.2020.10.001.","journal-title":"Adv Cancer Res"},{"issue":"2","key":"7454_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209\u201318. https:\/\/doi.org\/10.1172\/JCI24282.","journal-title":"J Clin Invest"},{"issue":"1","key":"7454_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s12879-024-09465-z","volume":"24","author":"S Zeng","year":"2024","unstructured":"Zeng S, Liu Z, Ke B, Zhang Y, Wang Q, Tan S. The non-invasive serum biomarkers contributes to indicate liver fibrosis staging and evaluate the progress of chronic hepatitis B. BMC Infect Dis. 2024;24(1):638. https:\/\/doi.org\/10.1186\/s12879-024-09465-z.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"7454_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.11817\/j.issn.1672-7347.2023.220622","volume":"48","author":"C Jiang","year":"2023","unstructured":"Jiang C, Liu J, Li R, et al. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48(5):698\u2013706. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2023.220622.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"2","key":"7454_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12253-019-00585-5","volume":"26","author":"P Luo","year":"2020","unstructured":"Luo P, Wu S, Yu Y, et al. Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Pathol Oncol Res. 2020;26(2):599\u2013603. https:\/\/doi.org\/10.1007\/s12253-019-00585-5.","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"7454_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif H, Ali MJ, Susheela AT, et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022;28(2):216\u201329. https:\/\/doi.org\/10.3748\/wjg.v28.i2.216.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"7454_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.rcl.2022.04.002","volume":"60","author":"E Altinmakas","year":"2022","unstructured":"Altinmakas E, Taouli B. Abbreviated liver magnetic resonance imaging protocols and applications. Radiol Clin North Am. 2022;60(5):695\u2013703. https:\/\/doi.org\/10.1016\/j.rcl.2022.04.002.","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"7454_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40644-020-00341-y","volume":"20","author":"IB Masokano","year":"2020","unstructured":"Masokano IB, Liu W, Xie S, Marcellin DFH, Pei Y, Li W. The application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges. Cancer Imaging. 2020;20(1):67. https:\/\/doi.org\/10.1186\/s40644-020-00341-y.","journal-title":"Cancer Imaging"},{"issue":"2","key":"7454_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","volume":"76","author":"F Foerster","year":"2022","unstructured":"Foerster F, Gairing SJ, M\u00fcller L, Galle PR. NAFLD-driven HCC: safety and efficacy of current and emerging treatment options. J Hepatol. 2022;76(2):446\u201357. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.007.","journal-title":"J Hepatol"},{"issue":"4","key":"7454_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","volume":"3","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Pinyol R, Kelley RK, et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer. 2022;3(4):386\u2013401. https:\/\/doi.org\/10.1038\/s43018-022-00357-2.","journal-title":"Nat Cancer"},{"issue":"3","key":"7454_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/jhep.2003.50127","volume":"37","author":"R Bataller","year":"2003","unstructured":"Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology. 2003;37(3):493\u2013503. https:\/\/doi.org\/10.1053\/jhep.2003.50127.","journal-title":"Hepatology"},{"issue":"5","key":"7454_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, et al. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology. 2023;164(5):766\u201382. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033.","journal-title":"Gastroenterology"},{"issue":"1","key":"7454_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/hep.32542","volume":"77","author":"PA Shah","year":"2023","unstructured":"Shah PA, Patil R, Harrison SA. NAFLD-related hepatocellular carcinoma: the growing challenge. Hepatology. 2023;77(1):323\u201338. https:\/\/doi.org\/10.1002\/hep.32542.","journal-title":"Hepatology"},{"issue":"9","key":"7454_CR21","doi-asserted-by":"publisher","first-page":"e70497","DOI":"10.7759\/cureus.70497","volume":"16","author":"H Babariya","year":"2024","unstructured":"Babariya H, Gaidhane SA, Acharya S, Kumar S. Pirfenidone as a cornerstone in the management of fibrotic interstitial lung diseases and its emerging applications: A comprehensive review. Cureus. 2024;16(9):e70497. https:\/\/doi.org\/10.7759\/cureus.70497.","journal-title":"Cureus"},{"issue":"Suppl 1","key":"7454_CR22","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/s0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38\u201353. https:\/\/doi.org\/10.1016\/s0168-8278(02)00429-4.","journal-title":"J Hepatol"},{"key":"7454_CR23","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823. https:\/\/doi.org\/10.1038\/ncomms3823.","journal-title":"Nat Commun"},{"issue":"2","key":"7454_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","volume":"33","author":"P Trivedi","year":"2021","unstructured":"Trivedi P, Wang S, Friedman SL. The power of Plasticity-Metabolic regulation of hepatic stellate cells. Cell Metab. 2021;33(2):242\u201357. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.026.","journal-title":"Cell Metab"},{"issue":"4","key":"7454_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","volume":"73","author":"J Bates","year":"2020","unstructured":"Bates J, Vijayakumar A, Ghoshal S, et al. Acetyl-CoA carboxylase Inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. J Hepatol. 2020;73(4):896\u2013905. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.037.","journal-title":"J Hepatol"},{"key":"7454_CR26","doi-asserted-by":"publisher","first-page":"2479192","DOI":"10.1155\/2023\/2479192","volume":"2023","author":"X Chen","year":"2023","unstructured":"Chen X, Lv X, Han M, et al. EMP1 as a potential biomarker in liver fibrosis: A bioinformatics analysis. Gastroenterol Res Pract. 2023;2023:2479192. https:\/\/doi.org\/10.1155\/2023\/2479192.","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"7454_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40164-022-00321-x","volume":"11","author":"N Zhang","year":"2022","unstructured":"Zhang N, Zhu HP, Huang W, et al. Unraveling the structures, functions and mechanisms of epithelial membrane protein family in human cancers. Exp Hematol Oncol. 2022;11(1):69. https:\/\/doi.org\/10.1186\/s40164-022-00321-x.","journal-title":"Exp Hematol Oncol"},{"issue":"48","key":"7454_CR28","doi-asserted-by":"publisher","first-page":"28824","DOI":"10.1074\/jbc.270.48.28824","volume":"270","author":"V Taylor","year":"1995","unstructured":"Taylor V, Welcher AA, Program AE, Suter U. Epithelial membrane protein-1, peripheral Myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem. 1995;270(48):28824\u201333. https:\/\/doi.org\/10.1074\/jbc.270.48.28824.","journal-title":"J Biol Chem"},{"issue":"2","key":"7454_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000533857","volume":"13","author":"K Yasukawa","year":"2024","unstructured":"Yasukawa K, Shimizu A, Kubota K, et al. Impact of liver fibrosis severity on oncological prognosis in hepatocellular carcinoma. Liver Cancer. 2024;13(2):150\u201360. https:\/\/doi.org\/10.1159\/000533857.","journal-title":"Liver Cancer"},{"issue":"2","key":"7454_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","volume":"155","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, et al. Fibrosis severity as a determinant of Cause-Specific mortality in patients with advanced nonalcoholic fatty liver disease: A Multi-National cohort study. Gastroenterology. 2018;155(2):443\u2013e45717. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.034.","journal-title":"Gastroenterology"},{"key":"7454_CR31","doi-asserted-by":"publisher","first-page":"1455383","DOI":"10.3389\/fimmu.2024.1455383","volume":"15","author":"B Li","year":"2024","unstructured":"Li B, Hu J, Xu H. Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1\u2009+\u2009macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma. Front Immunol. 2024;15:1455383. https:\/\/doi.org\/10.3389\/fimmu.2024.1455383.","journal-title":"Front Immunol"},{"issue":"1","key":"7454_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","volume":"21","author":"H Qin","year":"2023","unstructured":"Qin H, Abulaiti A, Maimaiti A, et al. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. J Transl Med. 2023;21(1):588. https:\/\/doi.org\/10.1186\/s12967-023-04468-x.","journal-title":"J Transl Med"},{"key":"7454_CR33","doi-asserted-by":"crossref","unstructured":"Wang Zyuan, Qian J, Lu X et al. A single-cell transcriptomic atlas characterizes liver non-parenchymal cells in healthy and diseased mice. bioRxiv. Published online 2021. https:\/\/api.semanticscholar.org\/CorpusID:235779889.","DOI":"10.1101\/2021.07.06.451396"},{"key":"7454_CR34","doi-asserted-by":"publisher","first-page":"832813","DOI":"10.3389\/fnmol.2022.832813","volume":"15","author":"J Chen","year":"2022","unstructured":"Chen J, Gao D, Chen J, et al. Pseudo-Temporal analysis of Single-Cell RNA sequencing reveals Trans-Differentiation potential of greater epithelial ridge cells into hair cells during postnatal development of cochlea in rats. Front Mol Neurosci. 2022;15:832813. https:\/\/doi.org\/10.3389\/fnmol.2022.832813.","journal-title":"Front Mol Neurosci"},{"key":"7454_CR35","doi-asserted-by":"publisher","unstructured":"Cheng C, Chen W, Jin H, Chen X. A review of Single-Cell RNA-Seq Annotation, Integration, and Cell-Cell communication. Cells. 2023;12(15). https:\/\/doi.org\/10.3390\/cells12151970.","DOI":"10.3390\/cells12151970"},{"key":"7454_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics"},{"key":"7454_CR37","doi-asserted-by":"publisher","first-page":"1261039","DOI":"10.1155\/2023\/1261039","volume":"2023","author":"M Zheng","year":"2023","unstructured":"Zheng M, Hu Y, Liu O, et al. Oxidative stress response biomarkers of ovarian cancer based on Single-Cell and bulk RNA sequencing. Oxid Med Cell Longev. 2023;2023:1261039. https:\/\/doi.org\/10.1155\/2023\/1261039.","journal-title":"Oxid Med Cell Longev"},{"issue":"43","key":"7454_CR38","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A. 2001;105(43):9954\u201360. https:\/\/doi.org\/10.1021\/jp003020w.","journal-title":"J Phys Chem A"},{"issue":"5","key":"7454_CR39","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1002\/mco2.378","volume":"4","author":"S Cheng","year":"2023","unstructured":"Cheng S, Zou Y, Zhang M, et al. Single-cell RNA sequencing reveals the heterogeneity and intercellular communication of hepatic stellate cells and macrophages during liver fibrosis. MedComm (2020). 2023;4(5):e378. https:\/\/doi.org\/10.1002\/mco2.378.","journal-title":"MedComm (2020)"},{"issue":"32","key":"7454_CR40","doi-asserted-by":"publisher","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","volume":"111","author":"K Iwaisako","year":"2014","unstructured":"Iwaisako K, Jiang C, Zhang M, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A. 2014;111(32):E3297\u20133305. https:\/\/doi.org\/10.1073\/pnas.1400062111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"7454_CR41","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1172\/JCI88845","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama Y, Wang P, Liang S, et al. Mesothelin\/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. J Clin Invest. 2017;127(4):1254\u201370. https:\/\/doi.org\/10.1172\/JCI88845.","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"7454_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/s0014-5793(01)02656-4","volume":"502","author":"S Dooley","year":"2001","unstructured":"Dooley S, Delvoux B, Streckert M, et al. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2\/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 2001;502(1\u20132):4\u201310. https:\/\/doi.org\/10.1016\/s0014-5793(01)02656-4.","journal-title":"FEBS Lett"},{"issue":"5","key":"7454_CR43","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jhep.2020.11.016","volume":"74","author":"H Chen","year":"2021","unstructured":"Chen H, Cai J, Wang J, et al. Targeting Nestin(+) hepatic stellate cells ameliorates liver fibrosis by facilitating T\u03b2RI degradation. J Hepatol. 2021;74(5):1176\u201387. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.016.","journal-title":"J Hepatol"},{"issue":"1 Pt 1","key":"7454_CR44","doi-asserted-by":"publisher","first-page":"G7","DOI":"10.1152\/ajpgi.1991.260.1.G7","volume":"260","author":"K M\u00e9sz\u00e1ros","year":"1991","unstructured":"M\u00e9sz\u00e1ros K, Bojta J, Bautista AP, Lang CH, Spitzer JJ. Glucose utilization by Kupffer cells, endothelial cells, and granulocytes in endotoxemic rat liver. Am J Physiol. 1991;260(1 Pt 1):G7\u201312. https:\/\/doi.org\/10.1152\/ajpgi.1991.260.1.G7.","journal-title":"Am J Physiol"},{"key":"7454_CR45","doi-asserted-by":"publisher","first-page":"153303382311636","DOI":"10.1177\/15330338231163677","volume":"22","author":"AG Quiroz Reyes","year":"2023","unstructured":"Quiroz Reyes AG, Lozano Sepulveda SA, Martinez-Acu\u00f1a N, et al. Cancer stem cell and hepatic stellate cells in hepatocellular carcinoma. Technol Cancer Res Treat. 2023;22:15330338231163677. https:\/\/doi.org\/10.1177\/15330338231163677.","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"7454_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jhep.2019.10.021","volume":"72","author":"B Sangro","year":"2020","unstructured":"Sangro B, Chan SL, Meyer T, Reig M, El-Khoueiry A, Galle PR. Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma. J Hepatol. 2020;72(2):320\u201341. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.021.","journal-title":"J Hepatol"},{"issue":"7","key":"7454_CR47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16(7):411\u201328. https:\/\/doi.org\/10.1038\/s41575-019-0145-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"7454_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Singal AG, Kanwal F, et al. Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology. Nat Rev Gastroenterol Hepatol. 2023;20(12):797\u2013809. https:\/\/doi.org\/10.1038\/s41575-023-00818-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"7454_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3727\/105221614X13919976902057","volume":"16","author":"MC Wallace","year":"2014","unstructured":"Wallace MC, Friedman SL. Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development. Gene Expr. 2014;16(2):77\u201384. https:\/\/doi.org\/10.3727\/105221614X13919976902057.","journal-title":"Gene Expr"},{"issue":"6","key":"7454_CR50","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jhep.2023.08.018","volume":"79","author":"F Ebrahimi","year":"2023","unstructured":"Ebrahimi F, Hagstr\u00f6m H, Sun J, et al. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: nationwide multigenerational cohort study. J Hepatol. 2023;79(6):1374\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.018.","journal-title":"J Hepatol"},{"issue":"1","key":"7454_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10555-024-10237-z","volume":"44","author":"D Sigorski","year":"2025","unstructured":"Sigorski D, Sejda A, Abualsaud N, Krawczyk E, Izycka-Swieszewska E, Kitlinska J. Neuropeptide Y in cancer-biological functions and potential clinical implications. Cancer Metastasis Rev. 2025;44(1):21. https:\/\/doi.org\/10.1007\/s10555-024-10237-z.","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"7454_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12032-016-0785-1","volume":"33","author":"X Lv","year":"2016","unstructured":"Lv X, Zhao F, Huo X, et al. Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma. Med Oncol. 2016;33(7):70. https:\/\/doi.org\/10.1007\/s12032-016-0785-1.","journal-title":"Med Oncol"},{"issue":"8","key":"7454_CR53","doi-asserted-by":"publisher","first-page":"11786","DOI":"10.18632\/aging.202876","volume":"13","author":"T Lin","year":"2021","unstructured":"Lin T, Lin Z, Mai P, Zhang E, Peng L. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma. Aging. 2021;13(8):11786\u2013807. https:\/\/doi.org\/10.18632\/aging.202876.","journal-title":"Aging"},{"issue":"1","key":"7454_CR54","doi-asserted-by":"publisher","first-page":"12740","DOI":"10.1038\/s41598-025-96488-4","volume":"15","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhang P. Gene expression profile of Anoikis reveals new subtypes of liver cancer and discovery of therapeutic targets and biomarkers. Sci Rep. 2025;15(1):12740. https:\/\/doi.org\/10.1038\/s41598-025-96488-4.","journal-title":"Sci Rep"},{"key":"7454_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ebiom.2019.01.009","volume":"40","author":"J Li","year":"2019","unstructured":"Li J, Wang Y, Ma M, et al. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-\u03b2 signaling. EBioMedicine. 2019;40:43\u201355. https:\/\/doi.org\/10.1016\/j.ebiom.2019.01.009.","journal-title":"EBioMedicine"},{"issue":"1","key":"7454_CR56","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12935-021-02266-3","volume":"21","author":"D Peng","year":"2021","unstructured":"Peng D, Wei C, Zhang X, et al. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers. Cancer Cell Int. 2021;21(1):566. https:\/\/doi.org\/10.1186\/s12935-021-02266-3.","journal-title":"Cancer Cell Int"},{"key":"7454_CR57","doi-asserted-by":"publisher","first-page":"1579661","DOI":"10.3389\/fimmu.2025.1579661","volume":"16","author":"Q Chen","year":"2025","unstructured":"Chen Q, Wang H, Liu Q, Luo C. CTHRC1: a key player in colorectal cancer progression and immune evasion. Front Immunol. 2025;16:1579661. https:\/\/doi.org\/10.3389\/fimmu.2025.1579661.","journal-title":"Front Immunol"},{"issue":"Suppl","key":"7454_CR58","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.3350\/cmh.2024.0837","volume":"31","author":"S Zhang","year":"2025","unstructured":"Zhang S, Mak LY, Yuen MF, Seto WK. Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B. Clin Mol Hepatol. 2025;31(Suppl):S182\u201395. https:\/\/doi.org\/10.3350\/cmh.2024.0837.","journal-title":"Clin Mol Hepatol"},{"key":"7454_CR59","doi-asserted-by":"publisher","first-page":"122745","DOI":"10.1016\/j.lfs.2024.122745","volume":"350","author":"M Cao","year":"2024","unstructured":"Cao M, Ke D, Zhou H. The role and molecular mechanism of CTHRC1 in fibrosis. Life Sci. 2024;350:122745. https:\/\/doi.org\/10.1016\/j.lfs.2024.122745.","journal-title":"Life Sci"},{"issue":"8","key":"7454_CR60","doi-asserted-by":"publisher","first-page":"e1793","DOI":"10.1002\/ctm2.1793","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Li Y, Zhang W, et al. The IGF2BP3\/Notch\/Jag1 pathway: A key regulator of hepatic stellate cell ferroptosis in liver fibrosis. Clin Transl Med. 2024;14(8):e1793. https:\/\/doi.org\/10.1002\/ctm2.1793.","journal-title":"Clin Transl Med"},{"issue":"Pt 3","key":"7454_CR61","doi-asserted-by":"publisher","first-page":"141678","DOI":"10.1016\/j.ijbiomac.2025.141678","volume":"306","author":"T Zhou","year":"2025","unstructured":"Zhou T, Zhu X, Ji X, He J, Zhao K. Histone acetylation activated-IGF2BP3 regulates Cyclin D1 mRNA stability to drive cell cycle transition and tumor progression of hepatocellular carcinoma. Int J Biol Macromol. 2025;306(Pt 3):141678. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141678.","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"7454_CR62","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41416-020-1022-4","volume":"123","author":"M Song","year":"2020","unstructured":"Song M, Pan Q, Yang J, et al. Galectin-3 favours tumour metastasis via the activation of \u03b2-catenin signalling in hepatocellular carcinoma. Br J Cancer. 2020;123(10):1521\u201334. https:\/\/doi.org\/10.1038\/s41416-020-1022-4.","journal-title":"Br J Cancer"},{"issue":"22","key":"7454_CR63","doi-asserted-by":"publisher","first-page":"12103","DOI":"10.1073\/pnas.210394297","volume":"97","author":"MP Playford","year":"2000","unstructured":"Playford MP, Bicknell D, Bodmer WF, Macaulay VM. Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proc Natl Acad Sci U S A. 2000;97(22):12103\u20138. https:\/\/doi.org\/10.1073\/pnas.210394297.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"7454_CR64","doi-asserted-by":"publisher","first-page":"e2319301121","DOI":"10.1073\/pnas.2319301121","volume":"121","author":"J Gautheron","year":"2024","unstructured":"Gautheron J, Elsayed S, Pistorio V, et al. ADH1B, the adipocyte-enriched alcohol dehydrogenase, plays an essential, cell-autonomous role in human adipogenesis. Proc Natl Acad Sci U S A. 2024;121(24):e2319301121. https:\/\/doi.org\/10.1073\/pnas.2319301121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"7454_CR65","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/HEP.0000000000001027","volume":"81","author":"Q Yuan","year":"2025","unstructured":"Yuan Q, Hodgkinson C, Liu X, et al. Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis. Hepatology. 2025;81(4):1304\u201317. https:\/\/doi.org\/10.1097\/HEP.0000000000001027.","journal-title":"Hepatology"},{"issue":"1\u20132","key":"7454_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mam.2007.10.001","volume":"29","author":"T Mello","year":"2008","unstructured":"Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med. 2008;29(1\u20132):17\u201321. https:\/\/doi.org\/10.1016\/j.mam.2007.10.001.","journal-title":"Mol Aspects Med"},{"issue":"5","key":"7454_CR67","first-page":"904","volume":"23","author":"SL Friedman","year":"1999","unstructured":"Friedman SL. Stellate cell activation in alcoholic fibrosis\u2013an overview. Alcohol Clin Exp Res. 1999;23(5):904\u201310.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"7454_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/a-2551-3320","volume":"45","author":"T Liu","year":"2025","unstructured":"Liu T, Zhang F, Feng Y, Han P, Gao Y. Alcohol-Metabolizing Enzymes, liver diseases and cancer. Semin Liver Dis. 2025;45(1):99\u2013113. https:\/\/doi.org\/10.1055\/a-2551-3320.","journal-title":"Semin Liver Dis"},{"key":"7454_CR69","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3389\/fphar.2018.00762","volume":"9","author":"Y Peng","year":"2018","unstructured":"Peng Y, Yang T, Huang K, Shen L, Tao Y, Liu C. Salvia miltiorrhiza ameliorates liver fibrosis by activating hepatic natural killer cells in vivo and in vitro. Front Pharmacol. 2018;9:762. https:\/\/doi.org\/10.3389\/fphar.2018.00762.","journal-title":"Front Pharmacol"},{"key":"7454_CR70","doi-asserted-by":"publisher","first-page":"1282203","DOI":"10.3389\/fphar.2023.1282203","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Liu W, Wang Y. The mechanisms of Tanshinone in the treatment of tumors. Front Pharmacol. 2023;14:1282203. https:\/\/doi.org\/10.3389\/fphar.2023.1282203.","journal-title":"Front Pharmacol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07454-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:02:12Z","timestamp":1767708132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07454-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7454"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07454-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7278297\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Institutional Animal Care and Use Committee (IACUC) of Sun Yat-sen University. All procedures were conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to submit the article for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}